Skip to main content
. 2023 Jul 25;16:200269. doi: 10.1016/j.tvr.2023.200269

Table 1.

Association of rs9357152 and rs4243652 with case-control status.

Stratum rs9357152 (HPV16+ve)
rs4243652 (HPV18+ve)
Ncases Ncontrols NTotal OR p Ncases Ncontrols NTotal OR p
Overall 307 561 868 1.16 (0.93–1.43) 0.19 88 558 646 1.56 (0.79–3.09) 0.20
LSIL (CIN1 + CIN2< 30y) 19 561 580 0.52 (0.21–1.24) 0.14 4 558 562 n.a.
HSIL (CIN2≥30y + CIN3) 89 561 650 1.01 (0.71–1.43) 0.97 11 558 569 1.11 (0.15–8.40) 0.92
Invasive 197 561 758 1.33 (1.03–1.70) 0.03 73 558 631 1.72 (0.84–3.52) 0.14
- Adenocarcinoma 19 561 580 1.58 (0.81–3.07) 0.18 27 558 585 2.96 (1.18–7.41) 0.02
- Squamous carcinoma 165 561 726 1.25 (0.96–1.64) 0.10 43 558 601 1.13 (0.40–3.23) 0.81

Stratified logistic regression analyses restricted to the disease type. Cervical intraepithelial neoplasia was differentiated into LSIL/low-risk (CIN1 + CIN2<30) and HSIL/high-risk (CIN2≥30 + CIN3) groups. Invasive cervical cancer was stratified into squamous epithelial cell carcinoma or adenocarcinoma. High-risk dysplasia (CIN2≥30 + CIN3) and invasive cancer were also combined together. For the LSIL analysis for rs4243652, numbers of HPV 18 positive samples were too small for statistical analysis. CI, confidence interval; OR, odds ratio for minor allele; P, P value from logistic regression analysis.